Antigenic linear peptide compounds
AssigneeNorthwestern University
InventorErwin Goldberg
Life of this patent
Estimating the term…
Abstract
The novel antigenic linear peptide compounds of this invention comprise sequences of from 10 to 14 amino acids which include the sequence arginine-methionine-valine-serine-glycine-glutamine-threonine-arginine-leu cine-aspartic acid, all of the amino acids with the exception of glycine being in their L-forms. The compounds have utility in vaccines for reducing fertility of mammals.
Claims6
The antigenic peptide compounds having chain lengths of from 10 to 14 amino acids arranged in a sequence from N-terminal to C-terminal amino acids which include the antigenic sequence Arg-Met-Val-Ser-Gly-Gln-Thr-Arg-Leu-Asp, said compounds being selected from the class of compounds consisting of:
- (a) Arg-Met-Val-Ser-Gly-Gln-Thr-Arg-Leu-Asp,
- (b) Arg-Met-Val-Ser-Gly-Gln-Thr-Arg-Leu-Asp-Leu,
- (c) Arg-Met-Val-Ser-Gly-Gln-Thr-Arg-Leu-Asp-Leu-Leu,
- (d) Arg-Met-Val-Ser-Gly-Gln-Thr-Arg-Leu-Asp-Leu-Leu-Gln, and
- (e) Arg-Met-Val-Ser-Gly-Gln-Thr-Arg-Leu-Asp-Leu-Leu-Gln-Arg,
- wherein Gly represents glycine, and Arg, Met, Val, Ser, Gln, Thr, Leu, Asp, respectively represent the L-amino acid forms of arginine, methionine, valine, serine, glutamine, threonine, leucine, and aspartic acid.
Dependencies are inferred from the claim text.